Agenda

1. Proposals from the Board of Directors

1. 1.1 Authorisation to the Board of Directors to issue warrants with pre-emption rights
2. 1.2 Authorisation to the Board of Directors to issue warrants without pre-emption rights
3. 1.3 Authorisation to the chairman of the meeting

Complete proposals

1. Proposals from the Board of Directors

The Board of Directors recommends that the general meeting consider the following proposals from the Board of Directors.

The Board of Directors proposes that the Board of Directors be authorized to issue warrants. The intention is for the Board of Directors to be able to issue warrants with pre-emptive rights for existing investors as well as warrants without pre-emptive rights for existing investors, depending on what fits with market conditions. The reason for issuing warrants without pre-emptive rights for existing investors can, for example, be to meet potential investors' desire to invest in the Company.

Issuing warrants to the Company's existing shareholders can be motivated by providing investors with opportunities to subscribe to warrants that can later be converted into shares in the Company at the specified exercise price that may be favourable in the future.

      1.1 Authorisation to the Board of Directors to issue warrants with pre-emption rights

The Board of Directors proposes a new authorization for the Board of Directors to issue warrants with pre-emption rights for the Company's existing shareholders and to effect the related capital increase by up to nominally DKK 200,000 for a period of 5 years from the date of the Extraordinary General Meeting under section 155 of the Danish Companies Act. This new authorisation will be included in a new article 5.2.3 of the Company's articles of association and worded as follows:

5.2.3 Selskabets bestyrelse The Company's board of directors is
er bemyndiget til ad authorised, pursuant to s. 155 of the Danish
én eller flere gange i Companies Act, cf. s. 169 thereof, in one or
henhold til several instances, to issue up to a total of
selskabslovens § 155, 4,000,000 warrants in the Company, which will
jf. § 169, at udstede entitle their holder(s) to subscribe for up
op til 4.000.000 to a total of nominally DKK 200,000 shares in
warrants i Selskabet the Company with pre-emption rights for the
med ret til tegning af existing shareholders at a subscription price
op til i alt nominelt and allocation determined by the board of
200.000 kr. directors. The subscription price may be
kapitalandele i below the market price at the time of the
Selskabet med decision of the board of directors.
fortegningsret for de
eksisterende
kapitalejere til en
kurs og fordeling, som
fastlægges af
bestyrelsen. Kursen
kan være under
markedskursen på
tidspunktet for
bestyrelsens
beslutning.
Samtidig er The Company's board of directors is also
bestyrelsen bemyndiget authorised to carry out any related share
til at foretage den capital increases, in one or several
dertil hørende instances, up to a total of nominally DKK
forhøjelse af 200,000 or such other amount as required
Selskabets following an adjustment of the number of
aktiekapital ad en warrants, the numbers of shares that issued
eller flere omgange warrants entitle the holder(s) to subscribe
med op til nominelt and/or the exercise price in accordance with
200.000 kr. eller et the terms governing the issued warrants. The
andet beløb som følge authorization is valid until 2 July 2029.
af eventuel regulering Shares issued pursuant to the authorization
af antallet af in this clause 5.2.3 must be paid up in full
udstedte warrants, by conversion of debt or by cash payment, be
antallet af negotiable instruments, be registered by name
kapitalandele, som de and be registered by the name of shareholders
udstedte warrants in the Company's shareholders' register. The
giver ret til at same restrictions on transferability as those
tegne, og/eller applying to the existing shares apply and no
tegningskursen i shareholder shall be obligated to have the
henhold til de til shares redeemed partly or in full.
enhver tid gældende
vilkår for de udstedte
warrants.Bemyndigelsen
løber frem til 2. juli
2029. Aktier udstedt i
henhold til
bemyndigelsen i dette
pkt. 5.2.3 skal
indbetales fuldt ud
ved gældskonvertering
eller kontant indskud,
være
omsætningspapirer,
skal lyde på navn og
noteres på navn i
Selskabets ejerbog.
Der gælder samme
indskrænkninger i
aktiernes
omsættelighed, som
gælder for de
eksisterende aktier,
og ingen aktionær er
forpligtet til at lade
aktier indløse helt
eller delvist.
Bestyrelsen er The board of directors is authorized to reuse
bemyndiget til at or reissue any lapsed, non-exercised
genanvende eller warrants, provided that such reuse or
genudstede eventuelle reissuance observes the terms and the
bortfaldne ikke expiration date set out in this
-udnyttede warrants, authorization.
forudsat at
genanvendelsen eller
genudstedelsen finder
sted inden for de
vilkår og tidsmæssige
begrænsninger, der
fremgår af
bemyndigelsen.

      1.2 Authorisation to the Board of Directors to issue warrants without pre-emption rights

The Board of Directors proposes a new authorization for the Board of Directors to issue warrants without pre-emption rights for the Company's existing shareholders and to effect the related capital increase by up to nominally DKK 200,000 for a period of 5 years from the date of the Extraordinary General Meeting under section 155 of the Danish Companies Act. This new authorisation will be included in a new article 5.2.4 of the Company's articles of association and worded as follows:

5.2.4 Selskabets bestyrelse The Company's board of directors is
er bemyndiget til ad authorised, pursuant to s. 155 of the Danish
én eller flere gange i Companies Act, cf. s. 169 thereof, in one or
henhold til several instances, to issue up to a total of
selskabslovens § 155,  4,000,000 warrants in the Company, which
jf. § 169, at udstede will entitle their holder(s) to subscribe for
op til 4.000.000 up to a total of nominally DKK 200,000 shares
 warrants i Selskabet in the Company without pre-emption rights for
med ret til tegning af the existing shareholders at a subscription
op til i alt nominelt price and allocation determined by the board
200.000 kr. of directors. The subscription price may be
kapitalandele i below the market price at the time of the
Selskabet uden decision of the board of directors.
fortegningsret for de
eksisterende
kapitalejere i
Selskabet til en kurs
og fordeling, som
fastlægges af
bestyrelsen. Kursen
kan være under
markedskursen på
tidspunktet for
bestyrelsens
beslutning.
Samtidig er The Company's board of directors is also
bestyrelsen bemyndiget authorised to carry out any related share
til at foretage den capital increases, in one or several
dertil hørende instances, up to a total of nominally DKK
forhøjelse af 200,000 or such other amount as required
Selskabets following an adjustment of the number of
aktiekapital ad en warrants, the numbers of shares that issued
eller flere omgange warrants entitle the holder(s) to subscribe
med op til nominelt and/or the exercise price in accordance with
200.000 kr. eller et the terms governing the issued warrants. The
andet beløb som følge authorization is valid until 2 July 2029.
af eventuel regulering Shares issued pursuant to the authorization
af antallet af in this clause 5.2.4 must be paid up in full
udstedte warrants, by conversion of debt or by cash payment, be
antallet af negotiable instruments, be registered by name
kapitalandele, som de and be registered by the name of shareholders
udstedte warrants in the Company's shareholders' register. The
giver ret til at same restrictions on transferability as those
tegne, og/eller applying to the existing shares apply and no
tegningskursen i shareholder shall be obligated to have the
henhold til de til shares redeemed partly or in full.
enhver tid gældende
vilkår for de udstedte
warrants.Bemyndigelsen
løber frem til 2. juli
2029. Aktier udstedt i
henhold til
bemyndigelsen i dette
pkt. 5.2.4 skal
indbetales fuldt ud
ved gældskonvertering
eller kontant indskud,
være
omsætningspapirer,
skal lyde på navn og
noteres på navn i
Selskabets ejerbog.
Der gælder samme
indskrænkninger i
aktiernes
omsættelighed, som
gælder for de
eksisterende aktier,
og ingen aktionær er
forpligtet til at lade
aktier indløse helt
eller delvist.
Bestyrelsen er The board of directors is authorized to reuse
bemyndiget til at or reissue any lapsed, non-exercised
genanvende eller warrants, provided that such reuse or
genudstede eventuelle reissuance observes the terms and the
bortfaldne ikke expiration date set out in this
-udnyttede warrants, authorization.
forudsat at
genanvendelsen eller
genudstedelsen finder
sted inden for de
vilkår og tidsmæssige
begrænsninger, der
fremgår af
bemyndigelsen.

      1.3 Authorisation to the chairman of the meeting

The Board of Directors proposes that the chairman of the meeting, with full right of substitution, be authorised to apply for registration of the resolutions passed and to make any such amendments thereto as the Danish Business Authority or other authorities may require or request as a condition for registration or approval, as well as to continuously make and apply for registration of linguistic and other non-substantive adjustments to the Company's Articles of Association.

*****

Majority requirements

Item 1.1 requires a qualified majority of votes, in accordance with section 106 of the Danish Companies Act.

Item 1.2 requires nine-tenths of the votes cast and of the share capital represented at the general meeting, according to section 107(2) of the Danish Companies Act, assuming that the new authorization in the proposed article 5.2.4 of the Company's articles of association may be utilized to issue new shares without pre-emption rights for existing shareholders at a price below market value. If item 1.2 is not adopted by at least nine-tenths of the votes cast and of the share capital represented at the general meeting, but is adopted with two-thirds of the votes cast and of the share capital represented at the general meeting, as per section 106(1) of the Danish Companies Act, the authorization in the proposed article 5.2.4 of the Company's articles of association will be limited to issuing shares without pre-emption rights for existing shareholders only at market price.

Item 1.3 of the agenda requires a simple majority of votes for adoption of the proposal, as per section 105 of the Danish Companies Act.

Share capital and voting rights

On the date of this notice, the nominal share capital of Curasight is DKK 994,694.55 divided into shares of a nominal value of DKK 0.05 each. Each share of nominally DKK 0.05 carries one vote at the general meeting (19,893,891 votes in total).

Participation and voting rights

All shareholders holding shares in the Company on the date of registration have a right to attend and vote at the Extraordinary General Meeting. The date of registration is Tuesday 25 June 2024.

The number of shares held by each shareholder at the date of registration is based on information recorded in the Company's shareholders' register at the expiry of the registration date as well as any notification received by the Company for registration but not yet entered in the shareholders' register at the expiry of the registration date.

Registration and notice of attendance

A shareholder wishing to attend the Extraordinary General Meeting is requested to notify the Company of the shareholder's attendance no later than on Friday 28 June 2024 at 23.59 (CET). Attendance can be notified by completing, signing, and returning a dated registration form (notification of attendance) by email to uk@curasight.com.Registration forms can be found at www.curasight.com/investor/general-meetings.

A shareholder or its proxy holder wishing to register an advisor for attending the Extraordinary General Meeting must state the name and email address of the advisor, when submitting the notification of attendance.

Proxy

Shareholders may attend the Extraordinary General Meeting by proxy to the Board of Directors or a third party. Proxies can be granted by completing, signing, and returning a dated proxy form. Proxy forms can be found at www.curasight.com/investor/general-meetings.

Proxies must be received by the Company no later than Friday 28 June 2024 at 23.59 (CET) as a scanned copy by email to uk@curasight.com.

Proxies can be revoked by the shareholder at any time. Revocation must be in writing by e-mail to uk@curasight.comand include proper identification of the shareholder revoking the proxy.

Postal vote

Shareholders may vote by post with respect to the agenda items of the Extraordinary General Meeting. Postal votes can be submitted by completing, signing, and returning a dated postal vote form. Postal vote forms can be found at www.curasight.com/investor/general-meetings.

Postal votes must be received by the Company no later than Monday 1 July 2024 at 9.00 AM (CET) as scanned copy by email to uk@curasight.com.

Postal votes cannot be revoked.

Information at the Company's website

Further information on the Extraordinary General Meeting and the following information and documents will be available at the Company's website www.curasight.com/investor/general-meetings until and including the date of the Extraordinary General Meeting:

1. The notice convening the Extraordinary General Meeting, including the agenda and complete proposals
2. The total number of shares and voting rights as of the date of this notice
3. The annual report for 2023
4. Proxy/postal voting forms applicable to the Extraordinary General Meeting

Questions from shareholders

Any shareholder can ask questions to the Board of Directors and the Executive Management about the Company in general or the agenda items prior to the Extraordinary General Meeting. Such questions can be submitted by email to uk@curasight.com.

Moreover, shareholders can ask questions at the Extraordinary General Meeting. If a question cannot be answered at the Extraordinary General Meeting, the answer will be published on the Company's website, www.curasight.com, no later than two weeks after the Extraordinary General Meeting.

Personal data

Prompted by requirements set out in the Danish Companies Act, the Company processes personal information about its shareholders as part of the administration of the company's register of shareholders and other communications. The following information is processed: Name, address, contact information, VP account number, shareholding and participation in events.

Language

The Extraordinary General Meeting will be conducted in Danish and all representatives of the Company and the chairman of the Extraordinary General Meeting will make their presentations and answer questions in Danish.

*****

The Board of Directors

17 June 2024